nodes	percent_of_prediction	percent_of_DWPC	metapath
Rocuronium—Vecuronium—ABCB1—adrenal gland cancer	0.116	1	CrCbGaD
Rocuronium—SLC22A1—Abacavir transmembrane transport—ABCB1—adrenal gland cancer	0.0712	0.0806	CbGpPWpGaD
Rocuronium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0438	0.0496	CbGpPWpGaD
Rocuronium—SLC22A1—Abacavir transport and metabolism—ABCB1—adrenal gland cancer	0.0409	0.0463	CbGpPWpGaD
Rocuronium—CHRNA1—ErbB2/ErbB3 signaling events—PRKACA—adrenal gland cancer	0.0381	0.0431	CbGpPWpGaD
Rocuronium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0372	0.0421	CbGpPWpGaD
Rocuronium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0354	0.04	CbGpPWpGaD
Rocuronium—CHRND—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0329	0.0373	CbGpPWpGaD
Rocuronium—CHRNA1—ErbB2/ErbB3 signaling events—CDC42—adrenal gland cancer	0.0323	0.0366	CbGpPWpGaD
Rocuronium—CHRNA1—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.028	0.0317	CbGpPWpGaD
Rocuronium—CHRNA2—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0266	0.0301	CbGpPWpGaD
Rocuronium—CHRND—Neuronal System—KCNJ5—adrenal gland cancer	0.0252	0.0286	CbGpPWpGaD
Rocuronium—CHRNA1—ErbB2/ErbB3 signaling events—BAD—adrenal gland cancer	0.0226	0.0255	CbGpPWpGaD
Rocuronium—CHRNA1—Neuronal System—KCNJ5—adrenal gland cancer	0.0215	0.0243	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Other—GNRHR—adrenal gland cancer	0.021	0.0237	CbGpPWpGaD
Rocuronium—CHRNA2—Neuronal System—KCNJ5—adrenal gland cancer	0.0204	0.0231	CbGpPWpGaD
Rocuronium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.0168	0.019	CbGpPWpGaD
Rocuronium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.0143	0.0162	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.0142	0.016	CbGpPWpGaD
Rocuronium—CHRM2—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.0141	0.016	CbGpPWpGaD
Rocuronium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.0136	0.0153	CbGpPWpGaD
Rocuronium—CHRND—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.0126	0.0143	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0122	0.0138	CbGpPWpGaD
Rocuronium—CHRNA1—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.0107	0.0121	CbGpPWpGaD
Rocuronium—CHRNA2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.0102	0.0115	CbGpPWpGaD
Rocuronium—CHRND—Neuronal System—PRKACA—adrenal gland cancer	0.00967	0.0109	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—KCNJ5—adrenal gland cancer	0.00936	0.0106	CbGpPWpGaD
Rocuronium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00905	0.0102	CbGpPWpGaD
Rocuronium—CHRNA1—Neuronal System—PRKACA—adrenal gland cancer	0.00822	0.0093	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00781	0.00884	CbGpPWpGaD
Rocuronium—CHRNA2—Neuronal System—PRKACA—adrenal gland cancer	0.00781	0.00884	CbGpPWpGaD
Rocuronium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00769	0.0087	CbGpPWpGaD
Rocuronium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00731	0.00827	CbGpPWpGaD
Rocuronium—CHRND—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.0068	0.0077	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00595	0.00673	CbGpPWpGaD
Rocuronium—CHRNA1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00578	0.00654	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00552	0.00624	CbGpPWpGaD
Rocuronium—CHRNA2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00549	0.00622	CbGpPWpGaD
Rocuronium—CHRM2—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00542	0.00613	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00523	0.00591	CbGpPWpGaD
Rocuronium—CHRND—Neuronal System—BRAF—adrenal gland cancer	0.00521	0.0059	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00478	0.00541	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00468	0.0053	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00468	0.0053	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.0046	0.0052	CbGpPWpGaD
Rocuronium—CHRNA1—Neuronal System—BRAF—adrenal gland cancer	0.00443	0.00501	CbGpPWpGaD
Rocuronium—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00439	0.00497	CbGpPWpGaD
Rocuronium—CHRNA2—Neuronal System—BRAF—adrenal gland cancer	0.00421	0.00476	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00417	0.00472	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00388	0.00439	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00381	0.00431	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.0038	0.00431	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—PRKACA—adrenal gland cancer	0.00359	0.00406	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00356	0.00403	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—SDHB—adrenal gland cancer	0.00353	0.00399	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00336	0.0038	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00318	0.00359	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00305	0.00345	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00305	0.00345	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00292	0.00331	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00278	0.00314	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00264	0.00299	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—SDHB—adrenal gland cancer	0.00258	0.00292	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00252	0.00286	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—SDHD—adrenal gland cancer	0.00227	0.00257	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—RRM1—adrenal gland cancer	0.00227	0.00257	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00214	0.00242	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.0021	0.00238	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00205	0.00232	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00204	0.0023	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00201	0.00228	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—BRAF—adrenal gland cancer	0.00193	0.00219	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00193	0.00218	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—GNAS—adrenal gland cancer	0.00185	0.00209	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00183	0.00207	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GNRHR—adrenal gland cancer	0.0018	0.00204	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00179	0.00203	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—MED12—adrenal gland cancer	0.0017	0.00192	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00168	0.0019	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00167	0.00189	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—SDHD—adrenal gland cancer	0.00166	0.00188	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—RRM1—adrenal gland cancer	0.00166	0.00188	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00163	0.00185	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—TSHR—adrenal gland cancer	0.00163	0.00184	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00158	0.00178	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00156	0.00177	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00153	0.00174	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.00152	0.00172	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—POMC—adrenal gland cancer	0.00124	0.00141	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—MED12—adrenal gland cancer	0.00124	0.0014	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PRKACA—adrenal gland cancer	0.00124	0.0014	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.00121	0.00137	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00117	0.00132	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00109	0.00124	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GNRH1—adrenal gland cancer	0.00108	0.00122	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00104	0.00118	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GNAS—adrenal gland cancer	0.001	0.00113	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CDC42—adrenal gland cancer	0.000992	0.00112	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SPRY2—adrenal gland cancer	0.000988	0.00112	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ABCB1—adrenal gland cancer	0.000984	0.00111	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TSHR—adrenal gland cancer	0.000963	0.00109	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—GNAS—adrenal gland cancer	0.000948	0.00107	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MEN1—adrenal gland cancer	0.000905	0.00102	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PRKACA—adrenal gland cancer	0.000903	0.00102	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GNAS—adrenal gland cancer	0.000732	0.000829	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ABCB1—adrenal gland cancer	0.000719	0.000813	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000703	0.000796	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000691	0.000782	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—POMC—adrenal gland cancer	0.000675	0.000764	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	0.000638	0.000722	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	0.000586	0.000663	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	0.000565	0.000639	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	0.00056	0.000634	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000546	0.000618	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PTGS2—adrenal gland cancer	0.000538	0.000609	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—POMC—adrenal gland cancer	0.000493	0.000558	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	0.00047	0.000532	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	0.000409	0.000463	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PTGS2—adrenal gland cancer	0.000393	0.000445	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	0.000377	0.000427	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	0.000372	0.000421	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000361	0.000408	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000269	0.000305	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	0.000213	0.000241	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	0.000179	0.000203	CbGpPWpGaD
